UPSTREAM BIO INC. - COMMON STOCK

Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress

06 أغسطس 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)

08 يوليو 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

15 يونيو 2025 04:45:00 بحسب Nasdaq GlobeNewswire

Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025

05 يونيو 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

04 يونيو 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Upstream Bio Appoints Stacy Price as Chief Technology Officer

20 مايو 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

06 مايو 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

12 مارس 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Upstream Bio to Present at Upcoming March Investor Conferences

25 فبراير 2025 05:00:01 بحسب Nasdaq GlobeNewswire

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 يناير 2025 05:00:01 بحسب Nasdaq GlobeNewswire

Upstream Bio Appoints Allison Ambrose as General Counsel

17 ديسمبر 2024 05:00:00 بحسب Nasdaq GlobeNewswire

Upstream Bio Announces Addition to Russell 2000® Index

16 ديسمبر 2024 05:00:04 بحسب Nasdaq GlobeNewswire

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

21 نوفمبر 2024 05:00:00 بحسب Nasdaq GlobeNewswire

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

07 نوفمبر 2024 04:00:01 بحسب Nasdaq GlobeNewswire

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

15 أكتوبر 2024 13:15:00 بحسب Nasdaq GlobeNewswire